Audited Results of Marksans Pharma Ltd. Company

(Rs in Cr.)	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Income	1,341.48	1,174.37	853.27	655.20	658.29
Manufacturing Expenses	32.95	30.73	26.04	14.24	11.27
Personnel Expenses	121.98	101.68	77.19	56.09	60.46
Selling Expenses	0	0	0	0	0
Administrative Expenses	184.19	197.98	131.17	98.52	95.25
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	1,017.91	970.32	713.34	563.30	544.57
Operating Profit	323.57	204.05	139.94	91.90	113.72
Other Recurring Income	103.53	69.83	62.07	60.48	42.25
Adjusted PBDIT	427.10	273.88	202.01	152.38	155.97
Financial Expenses	1.33	1.17	0.99	3.61	3.79
Depreciation	34.23	29.45	29.13	16.74	17.66
Other Write offs	0	0	0	0	0
Adjusted PBT	391.54	243.26	171.89	132.03	134.51
Tax Charges	90.84	54.99	38.13	29.17	30.52
Adjusted PAT	300.70	188.27	133.76	102.87	103.99
Non Recurring Items	1.04	-0.30	0.28	-0.59	0.05
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	300.70	188.27	133.76	102.87	103.99
Equity Dividend	36.25	27.19	22.66	10.17	10.23
Preference Dividend	0	0	0	0	0
Retained Earnings	771.26	505.78	345	247.31	155.21

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article